3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Neoplasms
2
Breast Neoplasms
2
Suicidal Ideation
1
Stomach Ulcer
1
Stomach Neoplasms
1
Skin Cancer Face
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Motor Activity
1
Meningeal Carcinomatosis
1
Lung Neoplasms
1
Hyperandrogenism
1
Hematologic Diseases
1
Glioblastoma
1
Gastrointestinal Hemorrhage
1
Gastrointestinal Diseases
1
Gastritis
1
Depression
1
Bursitis
1
Interventions
Temozolomide
100
Radiotherapy
49
Magnetic Resonance Spectroscopy
38
Radiation
28
Specimen Handling
25
pembrolizumab
22
Bevacizumab
22
Lomustine
16
Nivolumab
14
Surgical Procedures, Operative
10
atezolizumab
8
Cyclophosphamide
8
Biopsy
8
abemaciclib
7
Ipilimumab
7
fludarabine
6
Radiotherapy, Intensity-Modulated
6
Carboplatin
6
Aminolevulinic Acid
6
olaparib
5
Metformin
5
Drug Therapy
5
Diet, Ketogenic
5
Dianhydrogalactitol
5
poly ICLC
4
cemiplimab
4
Radiosurgery
4
Photons
4
Leukapheresis
4
Immunoglobulin G
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glioblastoma
×
Physical Examination
×
1 year
×
Clear all
NCT07409584
2026-05-18
SHINE-GLIO
University Hospital, Essen
Recruiting
176 enrolled